Corrigendum to “The role of serine/threonine protein kinases in cardiovascular disease and potential therapeutic methods” [Biomed. Pharmacother. 177 (2024) 117093] - 23/04/26

Yanjiao Wu ^a, Yuanming Zou ^a, Chunyu Song ^a, Kexin Cao ^a, Kexin Cai ^a, Shuxian Chen ^a, Zhaobo Zhang ^a, Danxi Geng ^a, Naijin Zhang ^{a, b, c, ⁎} , Hao Feng ^{d, ⁎} , Man Tang ^{e, ⁎} , Zhao Li ^{a, ⁎} , Guozhe Sun ^{a, ⁎} , Yixiao Zhang ^{f, ⁎} , Yingxian Sun ^{a, b, g, ⁎} , Ying Zhang ^{a, b, ⁎}

^a Department of Cardiology, The First Hospital of China Medical University, Shenyang, Liaoning, China 

^b Institute of Health Sciences, China Medical University, Shenyang, China 

^c Key Laboratory of Reproductive and Genetic Medicine (China Medical University), National Health Commission, Shenyang 110004, China 

^d Department of Ophthalmology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, China 

^e Department of Clinical Pharmacology, College of Pharmacy, China Medical University, Shenyang, Liaoning, China 

^f Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China 

^g Key Laboratory of Environmental Stress and Chronic Disease Control and Prevention, Ministry of Education, China Medical University, Shenyang, Liaoning, China 

^⁎ Corresponding authors at: Department of Cardiology, The First Hospital of China Medical University, Shenyang, Liaoning, China. Department of Cardiology, The First Hospital of China Medical University Shenyang Liaoning China ^⁎⁎ Corresponding authors.

Le texte complet de cet article est disponible en PDF.